Medication use evaluation: pharmacist rubric for performance improvement.

about

Best Practices for Medication Utilization Evaluations in Postsurgical Pain Management.Medication use evaluations as a research tool.

P2860

Q37732905-27AE7DFA-68F1-458E-A3E9-26A9595033BE Q53358092-E0F47DD1-3FF2-496F-B972-C1AF376F2322

P2860

Medication use evaluation: pharmacist rubric for performance improvement.

Item

http://www.wikidata.org/entity/Q38293085

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Medication use evaluation: pharmacist rubric for performance improvement.

@en

type

Item

label

Medication use evaluation: pharmacist rubric for performance improvement.

@en

prefLabel

Medication use evaluation: pharmacist rubric for performance improvement.

@en

P1476

Medication use evaluation: pharmacist rubric for performance improvement.

@en

P2093

Gregory Piazza

http://www.w3.org/2001/XMLSchema#string

Jean Connors

http://www.w3.org/2001/XMLSchema#string

John Fanikos

http://www.w3.org/2001/XMLSchema#string

Kathryn L Jenkins

http://www.w3.org/2001/XMLSchema#string

Samuel Z Goldhaber

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints

Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?

Effect of nesiritide in patients with acute decompensated heart failure

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.

Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

Target drug programs and medication use evaluation.

Results of the Medicare Health Support disease-management pilot program.

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

P304

5S-13S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1506

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

34 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25521847

http://www.w3.org/2001/XMLSchema#string

Medication use evaluation: pharmacist rubric for performance improvement.

about

P2860

P2860

Medication use evaluation: pharmacist rubric for performance improvement.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698